Table 8.
Effect of diets on subcutaneous fat fatty acid profile
| Fatty acid (%) |
Treatment1 |
|
||
|---|---|---|---|---|
| CON | SBO | LLO | SEM | |
| Myristic acid |
1.1b |
3.3a |
0.8c |
0.02 |
| Palmitic acid |
23.3a |
20.2b |
18.3c |
0.05 |
| Palmitoleic acid |
1.3b |
1.6a |
1.0c |
0.004 |
| Stearic acid |
15.5a |
12.5b |
12.5b |
0.04 |
| Oleic acid |
36.4b |
39.2a |
32.1c |
0.12 |
| Vaccenic acid |
2.0b |
2.8a |
1.8c |
0.01 |
| Linoleic acid |
14.2b |
11.6c |
27.5a |
0.05 |
|
cis9, trans11 CLA |
1.0b |
0.8c |
1.2a |
0.01 |
|
trans10, cis 12 CLA |
0.34a |
0.26c |
0.28b |
0.003 |
| α-Linolenic acid |
0.05c |
0.80a |
0.09b |
0.004 |
| Arachidonic acid |
1.0b |
0.6c |
1.4a |
0.01 |
| Eicosapentaenoic acid |
0.23a |
0.15c |
0.22b |
0.001 |
| Docosahexaenoic acid |
0.14a |
0.10b |
0.14a |
0.004 |
| Omega 6 (n6) |
15.3b |
12.4c |
28.9a |
0.04 |
| Omega 3 (n3) |
0.42c |
1.05a |
0.45b |
0.004 |
| Omega 6: Omega 3 (n6/n3) |
37.2b |
11.8c |
65.3a |
0.26 |
| Total SFA2 |
40.1a |
36.0b |
31.7c |
0.06 |
| Total MUFA3 |
41.0b |
44.6a |
35.9c |
0.13 |
| Total PUFA4 |
17.5b |
14.8c |
31.3a |
0.043 |
| MUFA: SFA |
1.03c |
1.24a |
1.16b |
0.003 |
| PUFA: SFA | 0.44b | 0.41c | 1.06a | 0.001 |
1 Data are given as means and pooled SEM, n = 4 per treatment group unless noted otherwise. CON, control diet with no added oil; SBO, metabolic syndrome diet + 13% soybean oil; LLO, metabolic syndrome diet + 13% low α-linolenic soybean oil. a,b,cLabeled means in a row without a common superscript letter, P < 0.05.
2 SFA- saturated fatty acid.
3 MUFA - Mono unsaturated fatty acid.
4 PUFA- Poly unsaturated fatty acid.